Brief: Bellicum Pharmaceuticals Announces Proposed $53 Mln Public Offering Of Preferred Stock And Warrants With Concurrent Private Placement
Aug 15 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS ANNOUNCES PROPOSED $53.0 MILLION
PUBLIC
OFFERING OF PREFERRED STOCK AND WARRANTS WITH CONCURRENT PRIVATE
PLACEMENT
* BELLICUM PHARMACEUTICALS - TO SELL SHARES OF SERIES 1
PREFERRED
STOCK & WARRANTS TO BUY COMMON STOCK IN PUBLIC OFFERING FOR
PROCEEDS OF ABOUT $53 MILLION
* BELLICUM PHARMACEUTICALS INC - EXPECTS CONCURRENT PRIVATE
PLACEMENT TO BE FOR AGGREGATE GROSS PROCEEDS OF $70.0 MILLION
Source text for Eikon: ID:nGNX6c10JP
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview